BioSpace News Archive

Sorrento Therapeutics, Inc. (NASDAQ: SRNE, “Sorrento”) announced today that it believes it has uncovered fraudulent attempts to manipulate the Company’s stock. On August 11, 2020, it was reported that an organization calling itself “Hindenburg Research” published claims regrading one of Sorrento’s COVID-19 diagnostic products. The report is believed to include false and/or misleading statements for the sole apparent purpose of negatively manipulat

Updated COVID-19 projections released by PolicyLab at Children’s Hospital of Philadelphia show that while spread of the virus is slowing in some hotspots like Arizona and Florida, it is continuing to take hold in the north and Midwest, overshadowing positive developments that have emerged and creating risk of widespread transmission in places that had previously worked hard to reduce case counts.

Adverum Biotechnologies, Inc., a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, announced the pricing of its underwritten public offering of 14,500,000 shares of its common stock at a public offering price of $13.00 per share.

QBiotics Group Limited, a life sciences company developing novel anticancer and wound healing pharmaceuticals, is pleased to announce that it has entered into an agreement with MSD, to evaluate use of its lead molecule tigilanol tiglate, in combination with Keytruda® in patients with unresectable melanoma.

Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster and more affordable, today announced a research collaboration with Dartmouth-Hitchcock Health (D-HH) to launch a clinical study of the Sherlock™ CRISPR SARS-CoV-2 kit for the detection of the novel coronavirus that causes COVID-19

LASEROPTEK Co., Ltd., a developer and manufacturer of world-class laser devices for aesthetic and medical dermatology, is pleased to announce the launch of its PALLAS Solid-State 311nm UVB laser in the United States

MANA RBM and CUSP announce the randomization of the first subject in ESCALATE, A Phase III Randomized Study Comparing Enzalutamide or Darolutamide with Radium-223 vs Enzalutamide or Darolutamide with Placebo and the Effect upon Symptomatic Skeletal Event-Free Survival for mCRPC Patients, clinicaltrials.gov #NCT04237584].

Vapotherm, Inc. announced the release of a low-cost, easy to use kit to help clinicians create a zone of relative negative pressure at the patient’s face which may mitigate the risk of transmission of potentially infectious particles while treating COVID-19 patients.

Cigna has named Noelle Eder, Global Chief Information Officer, effective September 14. She will report to David M. Cordani, President and Chief Executive Officer and will serve as a member of the Enterprise Leadership Team.

Swittons, a P360 company, has announced a new line of Internet of Things (IoT) enabled smart devices built specifically for pharmaceutical labs.